Market Cap | ₹1,01,089Cr |
ROE | 13.89% |
P/E Ratio(TTM) | 53.40 |
EPS(TTM) | 45.86 |
P/B Ratio | 7.05 |
Dividend Yield | 0.00% |
Industry P/E | 34.33 |
Book Value | 347.23 |
Debt to Equity | 0.59 |
Face Value | 1 |
Parent Organisation | Mankind Pharma |
Managing Director | Mr. Rajeev Juneja |
NSE Symbol | MANKIND |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 37.80 | ||
Cipla | NA (0.00%) | 22.70 | ||
Dr Reddy's Laboratories | NA (0.00%) | 18.34 | ||
Zydus Lifesciences | NA (0.00%) | 21.76 |